financetom
Business
financetom
/
Business
/
Victory Capital Sends Revised Proposal to Acquire Janus Henderson, Boosts Offer by $10 per Share
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Victory Capital Sends Revised Proposal to Acquire Janus Henderson, Boosts Offer by $10 per Share
Mar 17, 2026 5:18 AM

07:52 AM EDT, 03/17/2026 (MT Newswires) -- Victory Capital ( VCTR ) said Tuesday it sent a revised "superior" proposal to acquire Janus Henderson Group ( JHG ) for $40 per share in cash and 0.250 shares of Victory Capital ( VCTR ) common stock for each Janus Henderson ( JHG ) share, an increase of $10 per share from its previous proposal.

Under the revised proposal, Janus Henderson ( JHG ) shareholders would receive a total consideration of $56.84 per Janus Henderson ( JHG ) share, Victory Capital ( VCTR ) said.

Victory Capital ( VCTR ) said it does not agree with Janus Henderson's ( JHG ) assessment that its acquisition proposal presents risks in obtaining the required client consents. The asset management firm added that it believes both Janus Henderson's ( JHG ) and its own shareholders will support the transaction, contrary to the concerns raised by Janus Henderson's ( JHG ) board.

Janus Henderson ( JHG ) did not immediately reply to a request for comment from MT Newswires.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lending Club Q4 EPS Declines, Revenue Rises Above Analyst Projections
Lending Club Q4 EPS Declines, Revenue Rises Above Analyst Projections
Jan 28, 2025
04:45 PM EST, 01/28/2025 (MT Newswires) -- Lending Club (LC) late Tuesday reported a Q4 net income of $0.08 per diluted share compared with $0.09 a year earlier. Analysts polled by Factset expected $0.09. Revenue for the quarter ended Dec. 31 was $217.2 million compared with $185.6 million a year ago. Analysts were looking for $206.5 million from the specialty...
BXP Q4 FFO Declines, Revenue Rises; Full-Year Guidance Set
BXP Q4 FFO Declines, Revenue Rises; Full-Year Guidance Set
Jan 28, 2025
04:49 PM EST, 01/28/2025 (MT Newswires) -- BXP (BXP) reported Q4 funds from operations late Tuesday of $1.79 per diluted share, down from $1.82 a year earlier. Analysts polled by FactSet expected $1.80. Revenue for the quarter that ended Dec. 31 was $858.6 million, up from $828.9 million a year earlier. Analysts surveyed by FactSet expected $843.7 million. The real...
F5 Fiscal Q1 Non-GAAP EPS, Revenue Rise; Lifts Full-Year Outlook -- Shares Surge After Hours
F5 Fiscal Q1 Non-GAAP EPS, Revenue Rise; Lifts Full-Year Outlook -- Shares Surge After Hours
Jan 28, 2025
04:43 PM EST, 01/28/2025 (MT Newswires) -- F5 (FFIV) reported fiscal Q1 non-GAAP earnings late Tuesday of $3.84 per diluted share, up from $3.43 a year earlier. Analysts polled by FactSet expected $3.36. Net revenue for the quarter that ended Dec. 31 was $766.5 million, up from $692.6 million a year earlier. Analysts surveyed by FactSet expected $715.4 million. The...
Nurix Therapeutics Fiscal Q4 Net Loss Narrows, Revenue Falls
Nurix Therapeutics Fiscal Q4 Net Loss Narrows, Revenue Falls
Jan 28, 2025
04:42 PM EST, 01/28/2025 (MT Newswires) -- Nurix Therapeutics ( NRIX ) reported a fiscal Q4 net loss Tuesday of $0.75 per diluted share, narrowing from the loss of $0.77 a year earlier. Analysts polled by FactSet expected a loss of $0.69. Revenue in the three months ended Nov. 30 fell to $13.3 million from $15.2 million a year earlier....
Copyright 2023-2026 - www.financetom.com All Rights Reserved